Both plasma basic carboxypeptidases, carboxypeptidase B2 and carboxypeptidase N, regulate vascular leakage activity in mice
- 9 October 2021
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 20 (1) , 238-244
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Plasma kallikrein: the bradykinin-producing enzymeThrombosis and Haemostasis, 2013
- Inhibition of Allergic Bronchial Asthma by Thrombomodulin Is Mediated by Dendritic CellsAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Generation and characterization of inhibitory nanobodies towards thrombin activatable fibrinolysis inhibitorJournal of Thrombosis and Haemostasis, 2010
- Discovery of novel mechanisms and molecular targets for the inhibition of activated thrombin activatable fibrinolysis inhibitorJournal of Thrombosis and Haemostasis, 2008
- Pharmacologic Targets and Prototype Therapeutics in the Kallikrein-Kinin System: Bradykinin Receptor Agonists or AntagonistsThe Scientific World Journal, 2006
- DX-88 and HAE: a developmental perspectiveTransfusion and Apheresis Science, 2003
- Increased vascular permeability in C1 inhibitor–deficient mice mediated by the bradykinin type 2 receptorJournal of Clinical Investigation, 2002
- Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine lifeJournal of Clinical Investigation, 2002
- TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin ComplexJournal of Biological Chemistry, 1996
- Bradykinin-Degrading Enzymes: Structure, Function, Distribution, and Potential Roles in Cardiovascular PharmacologyJournal of Cardiovascular Pharmacology, 1992